Core Viewpoint - Huntsman Corporation has declared a cash dividend of $0.25 per share on its common stock, payable on June 30, 2025, to stockholders of record as of June 13, 2025 [1]. Company Overview - Huntsman Corporation is a global manufacturer and marketer of differentiated and specialty chemicals, with 2024 revenues of approximately $6 billion [2]. - The company offers thousands of chemical products sold worldwide, serving a diverse range of consumer and industrial end markets [2]. - Huntsman operates over 60 manufacturing, R&D, and operations facilities in around 25 countries and employs approximately 6,300 associates [2].

1Q25 Earnings Summary May 1, 2025 1 1st Quarter 2025 Earnings Summary Conference Call Friday, May 2, 2025 10:00 a.m. ET Webcast Link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=J4Z1igJk Participant dial-in numbers: Domestic callers: (877) 402-8037 International callers: (201) 378-4913 2 General Disclosure Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exch ...

Core Insights - Huntsman Corporation reported first quarter 2025 revenues of $1,410 million, a decrease of 4% compared to $1,470 million in the same period of 2024 [2][11] - The net loss attributable to Huntsman was $5 million, significantly improved from a net loss of $37 million in the prior year [11] - Adjusted EBITDA for the first quarter of 2025 was $72 million, down from $81 million in the same period of 2024, reflecting an 11% decline [11][17] Financial Performance - Revenues decreased across all segments: Polyurethanes by 2% to $912 million, Performance Products by 12% to $257 million, and Advanced Materials by 5% to $249 million [16][17] - Adjusted net loss for the first quarter was $19 million, compared to an adjusted net loss of $11 million in the prior year [11][17] - The diluted loss per share improved to $0.03 from $0.22 year-over-year [11] Segment Analysis - In the Polyurethanes segment, lower average selling prices were partially offset by higher sales volumes, leading to an increase in adjusted EBITDA by 8% [4] - The Performance Products segment saw a decrease in revenues primarily due to lower sales volumes and unplanned production outages, resulting in a 29% drop in adjusted EBITDA [5] - Advanced Materials experienced a decline in revenues due to lower average selling prices, with adjusted EBITDA decreasing by 16% [6] Liquidity and Capital Resources - Free cash flow used in continuing operations was $107 million, slightly higher than the $105 million used in the same period of 2024 [8][11] - As of March 31, 2025, Huntsman had approximately $1.3 billion in combined cash and unused borrowing capacity [8] Management Commentary - The CEO noted significant changes in short-term business conditions, with low visibility and customer uncertainty impacting demand trends in key markets [3] - The company is focusing on cost management, including workforce reductions and asset optimization, while prioritizing balance sheet protection and cash generation [3]

Historically, stocks struggle in May, making the selection of top momentum stocks a challenge. However, this can be done by applying the Richard Driehaus strategy, or the “buy high and sell higher” theory. To that end, stocks like Nomad Foods Limited (NOMD) , Hawkins, Inc. (HWKN) , and PCB Bancorp (PCB) have been selected as the momentum picks using the Driehaus strategy. A Detailed Look Into the Driehaus Strategy Regarding the strategy, Driehaus once said: “I would much rather invest in a stock that’s incr ...

Guidance spooks FMC investors despite a big earnings beat last night.FMC (FMC -7.13%) stock tumbled 6.5% through 10:55 a.m. ET this morning, despite soundly beating earnings expectations last night.Heading into the quarterly report, analysts expected FMC to earn $0.09 per share, adjusted for one-time items, on $784 million in revenue. In fact, FMC earned twice what it was "supposed to" -- $0.18 per share, and its sales came in at a strong $791.4 million. FMC Q1 earningsBut it's hard to call FMC's news "good ...

Financial Data and Key Metrics Changes - Q2 sales were $479 million, a 17% year-on-year decrease, including a $67 million impact from portfolio optimization, resulting in a 5% revenue decline excluding this impact [8][12] - Adjusted EBITDA was $108 million, down 14% year-over-year, with an organic decline of 4% [8][12] - Adjusted EPS, excluding acquisition amortization, was $0.99 per share, down 22% from the prior year [13] Business Line Data and Key Metrics Changes - Life Sciences sales declined 23% year-over-year to $172 million, primarily due to portfolio optimization initiatives [16] - Personal Care sales decreased by 14% year-over-year to $146 million, largely due to divestitures and low-margin product exits [21] - Specialty Additives sales fell by 15% to $134 million, with organic sales down 9% [26] Market Data and Key Metrics Changes - The demand environment was mixed, with slower trends than expected, particularly in Europe and the U.S. [7][43] - Intermediates generated $2 million in adjusted EBITDA, representing a 5.4% adjusted EBITDA margin, down from $12 million in the prior year [20] Company Strategy and Development Direction - The company is focused on achieving a $90 million cost savings target and has completed its restructuring efforts ahead of schedule [28] - Strategic priorities include enhancing financial performance through controllable factors and navigating the evolving tariff landscape [28][35] - The company aims for $100 million in incremental revenue from its Globalize and Innovate initiatives by fiscal year 2027 [31] Management's Comments on Operating Environment and Future Outlook - Management noted increasing economic uncertainty and anticipated softer consumer demand, prompting an adjustment to the fiscal year 2025 outlook [10][49] - The company expects flattish organic sales volume growth for the full fiscal year, with a positive inflection anticipated in the second half [45] - Management emphasized the importance of adapting and executing with discipline to navigate near-term challenges [10][50] Other Important Information - The company has over $700 million in liquidity and a manageable net leverage of 2.8 times, positioning it well to navigate the current environment [15] - The completion of portfolio optimization is expected to enhance long-term profitability despite short-term impacts [10][50] Q&A Session Summary Question: Order volatility and customer expectations - Management observed reduced volatility in orders over the last two quarters, with volumes picking up and pricing aligning with guidance [54][55] Question: Mitigation of risks related to U.S. produced China sales - Management indicated that over half of the risks could be mitigated through customer partnerships and production shifts, although some challenges remain [58][60] Question: Impact of delayed reciprocal tariffs on other regions - Management noted limited impact from tariffs outside of China, with most raw materials sourced regionally [67][68] Question: Competitive pressures in Specialty Additives - Management reported stable conditions in China, with pricing pressures continuing but manageable [71][72] Question: Cash flow expectations for the year - Management expects free cash flow to be in the range of $150 million to $200 million, depending on inventory and FX developments [91]

earnings conference call second quarter fiscal 2025 May 1, 2025 — Forward-Looking Statements — This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Ashland has identified some of these forward-looking statements with words such as "anticipates," "believes," "expects," "estimates," "is likely," "predicts," "projects," "forecasts," "objectives," "may," "will," "shoul ...

Tronox (TROX) Q1 2025 Earnings Call May 01, 2025 09:00 AM ET Company Participants Jennifer Guenther - Chief Sustainability Officer, Head of Investor Relations & External AffairsJohn Romano - CEOJohn Srivisal - Senior VP & CFOAziza Gazieva - Vice PresidentCaleb Boehnlein - Equity Research Senior AssociateMichael Leithead - Director - Equity ResearchAaron Rosenthal - Executive DirectorJohn Roberts - Managing Director Conference Call Participants Peter Osterland - Equity Research AnalystJames Cannon - Equity R ...

Financial Data and Key Metrics Changes - Q2 sales were $479 million, a 17% year-on-year decrease, including a $67 million impact from portfolio optimization. Excluding this, the revenue decline was 5% mainly due to lower carryover volumes and pricing [7][12] - Adjusted EBITDA was $108 million, down 14% year-over-year or 4% organically, partially offset by cost savings initiatives [7][13] - Adjusted EPS, excluding acquisition amortization, was $0.99 per share, down 22% from the prior year [14] Business Line Data and Key Metrics Changes - Life Sciences sales declined 23% year-over-year to $172 million, primarily due to portfolio optimization initiatives [16] - Personal Care sales decreased by 14% year-over-year to $146 million, largely due to divestitures and low-margin product exits [22] - Specialty Additives sales fell by 15% to $134 million, with organic sales down 9% due to soft demand and competitive pressures [28] Market Data and Key Metrics Changes - The demand environment was mixed, trending slower than expected, particularly in Europe and the U.S. [6][46] - The intermediates market faced challenges with persistent supply-demand imbalances, impacting pricing and margins [47] Company Strategy and Development Direction - The company is focused on achieving a $90 million cost savings target and has made significant progress on restructuring and manufacturing optimization [30][34] - Strategic priorities include enhancing financial performance through controllable factors and maintaining a disciplined capital allocation strategy [55] Management's Comments on Operating Environment and Future Outlook - Management noted increasing economic uncertainty and anticipated softer consumer demand, prompting adjustments to the fiscal year '25 outlook [11][52] - The company expects flattish organic sales volume growth for the full fiscal year, with a positive inflection anticipated in the second half led by Life Sciences [48] Other Important Information - The company has a strong financial foundation with over $700 million in liquidity and a manageable net leverage of 2.8 times [15] - The completion of portfolio optimization is expected to enhance long-term profitability and focus [30] Q&A Session Summary Question: Order volatility and customer stability - Management noted reduced volatility in orders, with volumes picking up and pricing aligning with guidance, but sentiment in certain markets remains impacted [58][60] Question: Mitigation of U.S. produced China sales risk - Management indicated that over half of the risk could be mitigated through customer partnerships and production shifts, although some challenges remain [62][66] Question: Impact of reciprocal tariffs on supply chains - Management stated that outside of China, the impact of tariffs is minimal, with most raw materials sourced regionally [72][74] Question: Competitive pressures in Specialty Additives - Management observed stability in China, with no further declines in volumes or prices, while Europe remains flattish [78][80] Question: Cash flow expectations for the year - Management expects free cash flow to be in the range of $150 million to $200 million, depending on inventory and FX developments [94][96]

THE WOODLANDS, Texas, May 1, 2025 /PRNewswire/ -- Huntsman Corporation (NYSE: HUN), a global manufacturer and marketer of differentiated and specialty chemicals, is pleased to announce that its Performance Products division has expanded its manufacturing site in Conroe, Texas to better serve the growing needs of its global customers in the semiconductor industry. Huntsman Corporation Announces New Purification and Packaging Capability through its E-GRADE® Unit in Conroe, Texas Peter Huntsman, Chairman, ...